[CLINICAL AND EXPERIMENTAL STUDY OF A SYNTHETIC ANTI-ARRHYTHMIA AGENT: RO 2-5803. ITS EFFECTS IN VENTRICULAR EXTRASYSTOLE].
D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac; D001281:Atrial Fibrillation; D035843:Biomedical Research; D001774:Blood Chemical Analysis; D005117:Cardiac Complexes, Premature; D004285:Dogs; D004562:Electrocardiography; D006323:Heart Arrest; D007275:Injections, Intravenous; D008660:Metabolism; D011342:Procainamide; D012106:Research; D014116:Toxicology; D014556:Urine; D018879:Ventricular Premature Complexes
D000889:Anti-Arrhythmia Agents; D011342:Procainamide
ARRHYTHMIA; AURICULAR FIBRILLATION; BLOOD CHEMICAL ANALYSIS; CLINICAL RESEARCH; DOGS; ELECTROCARDIOGRAPHY; EXPERIMENTAL LAB STUDY; EXTRASYSTOLE; HEART ARREST; INJECTIONS, INTRAVENOUS; METABOLISM; MYOCARDIAL DEPRESSANTS; PROCAINE AMIDE; TOXICOLOGIC REPORT; URINE
ETUDE CLINIQUE ET EXPERIMENTALE D'UN ANTIARYTHMIQUE DE SYNTHESE : LE RO 2-5803. SES EFFETS DANS L'EXTRASYSTOLIE VENTRICULAIRE.